CONKLING WILLIAM — SEC Form 4 filings
SEC reporting owner CIK 1852018. 17 Form 4 filings on record with FilingPulse; latest filed 2026-06-11.
Transaction summary — filings shown
Covers all 17 filings on record, filed 2024-02-15 to 2026-06-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | Chief Executive Officer | 8 | — | — | 10 |
| Cyclo Therapeutics, Inc. (CYTH) | Director | 5 | — | — | 6 |
| Protara Therapeutics, Inc. (TARA) | Chief Commercial Officer | 3 | — | — | 5 |
| IDT CORP (IDT) | Director | 1 | — | — | 1 |
Form 4 filings — CONKLING WILLIAM
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-11 | 4 | IDT CORP (IDT) | Grant/award (A): 673 @ $55.75 | EDGAR |
| 2026-06-03 | 4 | Protara Therapeutics, Inc. (TARA) | Tax withholding (F): 6,008 @ $4.34 | EDGAR |
| 2026-01-21 | 4 | Protara Therapeutics, Inc. (TARA) | Grant/award (A): 26,000 @ $0 · Grant/award (A): 158,000 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | Protara Therapeutics, Inc. (TARA) | Grant/award (A): 50,000 @ $0 · Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2025-04-24 | 4 | Rafael Holdings, Inc. (RFL) | Grant/award (A): 27,454 · Grant/award (A): 2,362 (derivative) · Grant/award (A): 5,485 (derivative) | EDGAR |
| 2025-03-25 | 4 | Rafael Holdings, Inc. (RFL) | Tax withholding (F): 14,814 @ $1.93 | EDGAR |
| 2025-03-03 | 4 | Cyclo Therapeutics, Inc. (CYTH) | Grant/award (A): 27,654 @ $0 | EDGAR |
| 2025-01-15 | 4 | Rafael Holdings, Inc. (RFL) | Grant/award (A): 60,000 @ $1.95 | EDGAR |
| 2024-12-23 | 4 | Rafael Holdings, Inc. (RFL) | Tax withholding (F): 12,807 @ $1.83 | EDGAR |
| 2024-11-18 | 4 | Cyclo Therapeutics, Inc. (CYTH) | Grant/award (A): 16,660 @ $0 | EDGAR |
| 2024-10-29 | 4 | Rafael Holdings, Inc. (RFL) | Tax withholding (F): 3,431 @ $1.84 | EDGAR |
| 2024-09-24 | 4 | Rafael Holdings, Inc. (RFL) | Tax withholding (F): 12,696 @ $1.73 | EDGAR |
| 2024-08-20 | 4 | Cyclo Therapeutics, Inc. (CYTH) | Grant/award (A): 8,731 @ $0 | EDGAR |
| 2024-06-25 | 4 | Rafael Holdings, Inc. (RFL) | Tax withholding (F): 13,295 @ $1.46 | EDGAR |
| 2024-06-05 | 4 | Cyclo Therapeutics, Inc. (CYTH) | Grant/award (A): 8,594 @ $0 · Grant/award (A): 15,562 (derivative) @ $0 | EDGAR |
| 2024-03-25 | 4 | Rafael Holdings, Inc. (RFL) | Tax withholding (F): 15,473 @ $1.71 | EDGAR |
| 2024-02-15 | 4 | Cyclo Therapeutics, Inc. (CYTH) | Grant/award (A): 6,330 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1852018 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →